ArticleTherapeutic advances in medical oncology2024

Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy.

Rhiannon Mellor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.